Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7546 AL 7560

Targeting Alzheimer's disease pathology: influence of nano-based drug delivery systems loaded with a combination of herbal and synthetic drugs

Mumtaz, Unnithan D, Bano A, Chauhan APS, Ali J, Khan MA.

Expert Opin Drug Deliv. 2025 Aug;22(8):1155-1170. doi: 10.1080/17425247.2025.2513440. Epub 2025 Jun 18.

Large language models for Alzheimer's disease drug discovery

Alkam T, Tarshizi E, Van Benschoten AH.

J Alzheimers Dis. 2025 Aug;106(3):799-822. doi: 10.1177/13872877251346890. Epub 2025 Jun 2.

Thioredoxin-interacting protein: an emerging target for Alzheimer's disease

Patil R, Parab SB, Bhatt LK.

Eur J Pharmacol. 2025 Sep 5;1002:177806. doi: 10.1016/j.ejphar.2025.177806. Epub 2025 Jun 4.

Biomaterials in Alzheimer's Disease: An Anti-Neuroinflammatory Perspective

Huang N, Huang W, Wang M, Shi J, Luo Y, Huang J.

Adv Healthc Mater. 2025 Jul;14(19):e2500498. doi: 10.1002/adhm.202500498. Epub 2025 Jun 8.

Fighting Alzheimer's naturally: Peptides as multitarget drug leads

Spinelli R, Sanchís I, Siano A.

Bioorg Med Chem Lett. 2025 Nov 1;127:130305. doi: 10.1016/j.bmcl.2025.130305. Epub 2025 Jun 8.

A Narrative Review Evaluating Diet and Exercise as Complementary Medicine for the Management of Alzheimer's Disease

Szabo-Reed AN, Key MN.

Nutrients. 2025 May 26;17(11):1804. doi: 10.3390/nu17111804.

Microbiome Engineering for Biotherapeutic in Alzheimer's Disease Through the Gut-Brain Axis: Potentials and Limitations

Renesteen E, Boyajian JL, Islam P, Kassab A, Abosalha A, Makhlouf S, Santos M, Chen H, Shum-Tim C, Prakash S.

Int J Mol Sci. 2025 Jun 2;26(11):5351. doi: 10.3390/ijms26115351.

Regulation of Blood-Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer's Disease and Brain Tumors

Plotnikov MB, Anishchenko AM, Khlebnikov AI, Schepetkin IA.

Molecules. 2025 May 28;30(11):2353. doi: 10.3390/molecules30112353.

Dual Aβ/tau epitope vaccines: a poorly explored strategy for Alzheimer's disease immunotherapy

León-Arcia K, Pérez-Leal G, Quintero-Álvarez H, Zamora-Loyarte DI, López-Armenteros M, de la Caridad Sánchez-Quesada A, Vázquez-Mojena Y.

Vaccine. 2025 Aug 13;61:127414. doi: 10.1016/j.vaccine.2025.127414. Epub 2025 Jun 21.

Sclerostin: A Potential Link between Osteoporosis and Alzheimer's Disease

Guo Z, Xu Q, Zhang K, Ma Y, Sheng S, Jing D, Sun X, Kan C, Yu X.

Neurodegener Dis. 2025;25(4):218-226. doi: 10.1159/000547072. Epub 2025 Jun 23.

Globalization of Alzheimer's disease clinical trials: Current characteristics and future goals

Cummings JL, Lindle J, Dalla I, Zhou Y, Zhong K, Cheng F.

Int Psychogeriatr. 2025 Dec;37(6):100108. doi: 10.1016/j.inpsyc.2025.100108. Epub 2025 Jun 23.

A Change of Mind: Targeting Amyloid-β with Better Safety Profile

Krick KE, Wilcock DM.

Annu Rev Pharmacol Toxicol. 2026 Jan;66(1):391-403. doi: 10.1146/annurev-pharmtox-062124-113434. Epub 2025 Jun 25.

Exploring prodrug approaches for Alzheimer's treatment: an overview

Kumari P, Kumar D, Chopade S, Karati D.

Neurodegener Dis Manag. 2026 Apr;16(2):177-190. doi: 10.1080/17582024.2025.2514990. Epub 2025 Jun 26.

Exosome-Mediated Delivery of Amyloid Beta Modulators: A Potential Therapeutic Strategy for Alzheimer's Disease

Mushtaq T, Hameed H, Cláudia Paiva-Santos A, Tariq U, Hameed A.

Mol Neurobiol. 2025 Dec;62(12):15349-15364. doi: 10.1007/s12035-025-05189-6. Epub 2025 Jul 8.

Alzheimer's disease basics: we all should know

Das S.

Neurol Res. 2026 Mar;48(3):330-359. doi: 10.1080/01616412.2025.2529560. Epub 2025 Jul 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias